Immunovant Inc. Common Stock vs Pacer Data & Infra Real Estate ETF — how do they compare? Immunovant Inc. Common Stock trades at $30.25 (market cap $6.25B), while Pacer Data & Infra Real Estate ETF trades at $28.93 (market cap $296.73M). The key difference: Immunovant Inc. Common Stock is far larger — about 21.1× Pacer Data & Infra Real Estate ETF's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Pacer Data & Infra Real Estate ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Pacer Data & Infra Real Estate ETF for 10 Days on average.
| IMVT | SRVR | |
|---|---|---|
Market Cap | $6.25B | $296.73M |
Volume | 1,755,411 | 243,654 |
Sector | Health | Sector/Thematic |
52-Week High | $44.96 | $35.74 |
52-Week Low | $17.03 | $28.17 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $5.35B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Pacer Data & Infra Real Estate ETF seeks exposure to real estate companies that own digital infrastructure assets. Its holdings may include data centers, cell towers, fiber networks, and other connectivity-related real estate.
Read more on SRVR →